Immune globulin/Hyaluronidase

N/A

Report date: 2026/01/30 10:49:30

Base Information

Drug NameImmune globulin/Hyaluronidase
Drug Alias Name人类免疫球蛋白（百特）Human immunoglobulin (Baxter)Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase静脉注射人类免疫球蛋白（百特）Immune Globulin Infusion 10% (Human) with Recombinant +[8] 
ClassificationBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPrimary Immunodeficiency DiseasesAgammaglobulinemiaMotor Neuron Disease +[4] 
Global Approved IndicationsPrimary Immunodeficiency DiseasesAgammaglobulinemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2014/09/12
Country/TerritoryUnited StatesJapan
CombinationsYes
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesBaxter Healthcare Corporation Of Puerto Rico (Utah)Takeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPrimary Immunodeficiency DiseasesAgammaglobulinemiaMotor Neuron Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA02
Related LinksWikipediaDrugBankKEGG